Description: NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It provides facemasks, undereye patches, blister shield foot care, hexagel, cracked heel repair patches, and fever patch. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was founded in 1997 and is based in Langhorne, Pennsylvania.
Home Page: nexgel.com
NXGL Technical Analysis
2150 Cabot Boulevard West
Langhorne,
PA
19047
United States
Phone:
215 702 8550
Officers
| Name | Title |
|---|---|
| Mr. Adam R. Levy | CEO, Pres & Director |
| Mr. Adam E. Drapczuk III | Chief Financial Officer |
| Mr. David Stefansky | Exec. Director |
| Mr. Gregory Robb | VP of Operations |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8815 |
| Price-to-Sales TTM: | 4.253 |
| IPO Date: | 2021-12-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 10 |